Patient-Derived Xenograft Mouse Model of a Rare Gynecologic Malignancy: Personalized Medicine for the Treatment of Mesonephric-Like AdenocarcinomaK. Kasuya(Osaka City University), Tadashi Kimura(Osaka University)CureusOctober 27, 202510.7759/cureus.95530Cited by 0SaveCiteExport RISWatch citationsRelated PapersExosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells|BMC Cancer|2018|148Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment|Cancers|2024|17Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer|BMC Cancer|2022|7